Free Trial

Ventyx Biosciences (VTYX) SEC Filings & 10K Form

Ventyx Biosciences logo
$2.02 -0.05 (-2.42%)
Closing price 04:00 PM Eastern
Extended Trading
$2.10 +0.09 (+4.21%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ventyx Biosciences SEC Filings

DateFilerForm TypeView
06/17/2025
7:00 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
1:26 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
2:10 PM
HULME ALLISON (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:11 PM
Cadoret-Manier Onaiza (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:04 PM
Gujrathi Sheila (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:06 PM
Ventyx Biosciences (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:08 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:01 PM
Affinity Asset Advisors, LLC (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G
05/16/2025
5:41 PM
Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
5:40 PM
Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:29 PM
CITADEL ADVISORS LLC (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G/A
05/15/2025
12:10 PM
BANK OF AMERICA CORP /DE/ (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:30 PM
Ventyx Biosciences (Filer)
Form DEFA14A
04/23/2025
3:45 PM
Ventyx Biosciences (Filer)
Form ARS
04/23/2025
3:15 PM
Ventyx Biosciences (Filer)
Form DEF 14A
04/08/2025
2:14 PM
Sio Capital Management, LLC (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G/A
04/03/2025
3:21 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:40 PM
NSV Partners III LP (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13D/A
04/01/2025
3:35 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:36 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:32 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:17 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
7:15 AM
Ventyx Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
4:21 PM
Ventyx Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:09 PM
BANK OF AMERICA CORP /DE/ (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G
02/13/2025
7:59 AM
Flynn James E (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G/A
02/10/2025
11:59 AM
Sio Capital Management, LLC (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G
01/29/2025
5:58 PM
Point72 Asset Management, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SCHEDULE 13G
01/14/2025
8:15 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
5:50 PM
Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:52 PM
Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:53 PM
Moore Matthew Richard (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:54 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:57 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:33 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:46 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
7:05 PM
Gujrathi Sheila (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:49 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:50 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:48 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
12/11/2024
4:21 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
8:07 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2024
11:15 PM
Ventyx Biosciences (Filer)
Form EFFECT
11/15/2024
3:59 PM
Ventyx Biosciences (Filer)
Form 424B3
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G/A
11/14/2024
2:06 PM
Cormorant Asset Management, LP (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G/A
11/14/2024
7:57 AM
Flynn James E (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G/A
11/07/2024
3:58 PM
Ventyx Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:13 PM
Ventyx Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/30/2024
3:40 PM
Ventyx Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
09/23/2024
7:18 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:47 PM
Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2024
7:15 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:48 PM
Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:35 PM
Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VTYX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners